PHARMAPRESS JOURNALS NOW ON MEDLINE®

PharmaPress Ltds three Current Opinion pharmaceutical research review journals have recently been accepted for citation and indexing in Index Medicus and MEDLINE® -- the US National Library of Medicine's (NLM) premier bibliographic database. MEDLINE covers over 4,300 biomedical journals and contains 11 million references and abstracts.

Commented Tara Dyson, Director of PharmaPress: We are delighted that our journals are to be included on the MEDLINE database. As MEDLINE provides such a vast source of medical information, nearly all biomedical scientists regularly use this service. In addition, journals undergo a rigorous evaluation process before they are accepted by the NLM, so our recent acceptance is recognition of the quality of our publications."

PharmaPress Current Opinion journals keep readers up-to-date with the latest research on developmental drugs and enabling technologies across all therapeutic areas. They contain contributions from internationally recognized researchers and are peer reviewed by editorial boards of distinguished members of the scientific community.

The journals are:
*Current Opinion in Drug Discovery and Development
*Current Opinion in Investigational Drugs
*Current Opinion in Molecular Therapeutics

(ends)

Notes to Editors
1) Review copies of the Current Opinion journals are available. If you would like a copy please contact Christine Suggars, details below.
2) The NLM web site is: http://www.nlm.nih.gov

Background information
PharmaPress Ltd is the publishing arm of Current Drugs Ltd. It produces the Current Drug Discovery magazine, IDrugs journal and three Current Opinion journals covering investigational drug research. The journals and magazine contain authoritative articles, written by the world's leading physicians and scientists involved in medical research. PharmaPress is part of the privately owned Current Science Group of companies. Sample issues of all the Current Opinion and IDrugs journals and Current Drug Discovery can be downloaded in PDF format from Current Drugs web site http://www.current-drugs.com. A free sample printed copy can also be requested from this site or via email at info@current-drugs.com

MEDIA CONTACT (details not for publication please):
Christine Suggars, Media & Communications Manager. Tel: +44-(0)20-7631-9147 (direct line), Fax: +44-(0)20-7580-5646. E-mail: info@current-drugs.com